Xiaoying Zhao

2.6k total citations
36 papers, 651 citations indexed

About

Xiaoying Zhao is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaoying Zhao has authored 36 papers receiving a total of 651 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaoying Zhao's work include Lymphoma Diagnosis and Treatment (7 papers), Gastric Cancer Management and Outcomes (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Xiaoying Zhao is often cited by papers focused on Lymphoma Diagnosis and Treatment (7 papers), Gastric Cancer Management and Outcomes (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Xiaoying Zhao collaborates with scholars based in China, Australia and United States. Xiaoying Zhao's co-authors include Yun Liang, Xin He, Zhigang Chen, Teng Yu, Xin He, Zhigang Chen, Tao Fu, Xuyan Yang, Qingqing Wang and Huiying Wang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Xiaoying Zhao

33 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoying Zhao China 14 250 203 198 110 105 36 651
Lobna Ayadi Tunisia 14 191 0.8× 147 0.7× 139 0.7× 82 0.7× 68 0.6× 87 613
M.T. Allende Spain 13 165 0.7× 184 0.9× 122 0.6× 99 0.9× 34 0.3× 25 589
Bridget Charbonneau United States 13 250 1.0× 200 1.0× 173 0.9× 237 2.2× 80 0.8× 17 795
Fernando Augusto Soares Brazil 16 213 0.9× 248 1.2× 126 0.6× 95 0.9× 43 0.4× 71 723
Giuseppina Massini Italy 14 292 1.2× 234 1.2× 346 1.7× 120 1.1× 30 0.3× 39 805
Atsuo Okamura Japan 14 187 0.7× 142 0.7× 140 0.7× 68 0.6× 34 0.3× 61 577
James Dalton United States 8 210 0.8× 550 2.7× 228 1.2× 105 1.0× 51 0.5× 14 1.3k
Ik‐Chan Song South Korea 17 208 0.8× 236 1.2× 48 0.2× 139 1.3× 62 0.6× 87 720
Paolo Fiumara Italy 12 282 1.1× 196 1.0× 303 1.5× 205 1.9× 23 0.2× 28 684
Magdalena Chechlińska Poland 15 370 1.5× 246 1.2× 122 0.6× 186 1.7× 22 0.2× 38 790

Countries citing papers authored by Xiaoying Zhao

Since Specialization
Citations

This map shows the geographic impact of Xiaoying Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoying Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoying Zhao more than expected).

Fields of papers citing papers by Xiaoying Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoying Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoying Zhao. The network helps show where Xiaoying Zhao may publish in the future.

Co-authorship network of co-authors of Xiaoying Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoying Zhao. A scholar is included among the top collaborators of Xiaoying Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoying Zhao. Xiaoying Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Xiaoying, Yihua Fan, Jiya Sun, et al.. (2025). Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A systematic review and meta-analysis of randomized controlled trials. International Immunopharmacology. 149. 114223–114223.
4.
Li, Bin, Donghao Li, Linjun Cai, et al.. (2023). Transcriptome-wide profiling of RNA N4-cytidine acetylation in Arabidopsis thaliana and Oryza sativa. Molecular Plant. 16(6). 1082–1098. 15 indexed citations
5.
Zhao, Xiaoying, et al.. (2022). Nurses’ Intentions, Awareness and Barriers in Reporting Adverse Events: A Cross-Sectional Survey in Tertiary Hospitals in China. Risk Management and Healthcare Policy. Volume 15. 1987–1997. 7 indexed citations
6.
Huang, Mingzhu, Xiaoying Zhao, Siyuan Chen, et al.. (2020). Severe loss of visceral fat and skeletal muscle after chemotherapy predicts poor prognosis in metastatic gastric cancer patients without gastrectomy. Journal of Cancer. 11(11). 3310–3317. 14 indexed citations
7.
Zhao, Xiaoying, et al.. (2020). The Prognostic Impact of Body Mass Index in Patients with Diffuse Large B-Cell Lymphoma: A Meta-Analysis. Nutrition and Cancer. 73(11-12). 2336–2346. 5 indexed citations
9.
Liu, Rujiao, Xiaoying Zhao, Weijian Guo, et al.. (2019). Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab. Clinical & Translational Oncology. 22(6). 928–934. 12 indexed citations
10.
Yuan, Xianggui, Yurong Huang, Teng Yu, et al.. (2019). Primary central nervous system lymphoma in China: a single-center retrospective analysis of 167 cases. Annals of Hematology. 99(1). 93–104. 22 indexed citations
11.
Zhang, Lei, Xin He, Yun Liang, et al.. (2018). Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells. Annals of Hematology. 97(12). 2353–2362. 7 indexed citations
12.
Huang, Qi, Shu Li, Pu Cheng, et al.. (2017). High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis. World Journal of Gastroenterology. 23(27). 5018–5018. 34 indexed citations
13.
He, Xin, Zhigang Chen, Tao Fu, et al.. (2014). Ki-67 is a valuable prognostic predictor of lymphoma but its utility varies in lymphoma subtypes: evidence from a systematic meta-analysis. BMC Cancer. 14(1). 153–153. 116 indexed citations
14.
Li, Jin, Chenchen Wang, Qin Su, et al.. (2014). The prognostic significance of MET overexpression in Chinese patients with gastric adenocarcinoma.. Journal of Clinical Oncology. 32(3_suppl). 53–53. 1 indexed citations
16.
Lin, Tiao, Xun-Zi Cai, Xiaoying Zhao, et al.. (2012). Comparison of clinical efficacy and safety between denosumab and alendronate in postmenopausal women with osteoporosis: a meta-analysis. International Journal of Clinical Practice. 66(4). 399–408. 46 indexed citations
17.
Zhao, Xiaoying, Ye Guo, Yongxue Zhu, et al.. (2012). A prospective phase II study of induction chemotherapy and nimotuzumab for resectable locally advanced head and neck squamous cell carcinoma.. Journal of Clinical Oncology. 30(15_suppl). e16039–e16039. 3 indexed citations
18.
Liang, Yun, et al.. (2011). Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity. Journal of Zhejiang University SCIENCE B. 12(7). 568–574. 23 indexed citations
19.
Yuan, Xianggui, Feifei Chen, Yimiao Zhu, et al.. (2011). High prevalence of hepatitis B virus infection in HIV-negative Castleman's disease. Annals of Hematology. 91(6). 857–861. 7 indexed citations
20.
Zhang, Xiao­hong, et al.. (2005). Relationship between the As2O3 Induced Expression of NF-κB and Drug Resistance in K562/ADR Cells.. Blood. 106(11). 4414–4414. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026